Tuesday, 10 July 2012

Bristol-Myers starts tender offer for Amylin



(Reuters) - Bristol-Myers Squibb Co on Tuesday launched its tender offer to buy all outstanding shares of biotechnology company Amylin Pharmaceuticals Inc.





via Reuters: Health News Read More Here..

No comments:

Post a Comment